- Home
- VVPR vs XLO Comparison
VVPR vs XLO Comparison
Compare VVPR & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VVPR
- XLO
- Stock Information
- Founded
- VVPR 2014
- XLO 2016
- Country
- VVPR United Kingdom
- XLO United States
- Employees
- VVPR N/A
- XLO N/A
- Industry
- VVPR Power Generation
- XLO Biotechnology: Pharmaceutical Preparations
- Sector
- VVPR Utilities
- XLO Health Care
- Exchange
- VVPR Nasdaq
- XLO Nasdaq
- Market Cap
- VVPR 40.2M
- XLO 41.8M
- IPO Year
- VVPR 2016
- XLO 2021
- Fundamental
- Price
- VVPR $2.45
- XLO $0.76
- Analyst Decision
- VVPR
- XLO Buy
- Analyst Count
- VVPR 0
- XLO 1
- Target Price
- VVPR N/A
- XLO $2.00
- AVG Volume (30 Days)
- VVPR 572.0K
- XLO 996.7K
- Earning Date
- VVPR 01-01-0001
- XLO 11-13-2025
- Dividend Yield
- VVPR N/A
- XLO N/A
- EPS Growth
- VVPR N/A
- XLO N/A
- EPS
- VVPR N/A
- XLO N/A
- Revenue
- VVPR $61,000.00
- XLO $31,804,000.00
- Revenue This Year
- VVPR N/A
- XLO $519.70
- Revenue Next Year
- VVPR N/A
- XLO $44.57
- P/E Ratio
- VVPR N/A
- XLO N/A
- Revenue Growth
- VVPR 281.25
- XLO 588.40
- 52 Week Low
- VVPR $0.62
- XLO $0.62
- 52 Week High
- VVPR $8.88
- XLO $1.70
- Technical
- Relative Strength Index (RSI)
- VVPR 37.23
- XLO 47.75
- Support Level
- VVPR $2.05
- XLO $0.73
- Resistance Level
- VVPR $3.64
- XLO $0.81
- Average True Range (ATR)
- VVPR 0.35
- XLO 0.06
- MACD
- VVPR -0.03
- XLO -0.00
- Stochastic Oscillator
- VVPR 27.04
- XLO 54.58
About VVPR VivoPower International PLC
Vivopower International PLC is a sustainable energy solutions B Corporation specializing in electric solutions for customized and ruggedized fleet applications, battery and microgrids, solar, and critical power technology and services. The company's core purpose is to provide turnkey decarbonization solutions that help customers progress toward net-zero carbon status. VivoPower operates across five reportable segments: Electric Vehicles, Sustainable Energy Solutions, Solar Development, Digital Assets, and Corporate Office, with personnel and operations in Australia, the Netherlands, the United Kingdom, the United States, and the Philippines.
About XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.